Meetings & Events

Primary Aldosteronism: Once a Zebra, Now a Horse

June 16, 2021

Session Date and Time:

Saturday, September 11
2:00–2:45 PM EDT

Learning Objectives:

  1. Identify primary aldosteronism as a highly prevalent and unrecognized syndrome that manifests across a continuum of severity.
  2. Describe how to recalibrate diagnostic interpretations to maximize diagnosis and treatment.
  3. Recognize how primary aldosteronism syndrome contributes to the pathogenesis of a large proportion of “idiopathic” hypertension and cardiovascular disease.

Return to the full CEU 2021 program.

Register Now

Faculty Information

Anand Vaidya, MD, MMScDr. Vaidya is currently the Director of the Center for Adrenal Disorders at Brigham and Women’s Hospital and an Associate Professor at Harvard Medical School. He oversees the multi-disciplinary clinical care of patients with adrenal diseases and runs a translational research program.

His research has helped characterize and redefine the severity spectrum of primary aldosteronism, the optimal approaches to treating primary aldosteronism, the genetics of pheochromocytoma-paraganglioma syndromes, and the systemic consequences of adrenal tumors and hypercortisolism.

Dr. Vaidya is a dedicated educator; he is the director of the pre-clerkship endocrinology curriculum at HMS, he directs the interactive medical case series for The New England Journal of Medicine, and he regularly teaches clinical audiences about updates in adrenal diseases.


Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.